And the cuts will continue: Pfizer said it sees R&D spending falling to between $8 billion and $8.5 billion by 2012. R&D cuts are common in the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Plans to Cut Billions in Annual R&D Spending
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account